| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JUNO | Juno Therapeutics, Inc. | PIEN HOWARD H | Director | Mar 05, 2018 | Option Exercise | $87.00 | 116,637 | 10,147,419 | 5,050 | Mar 07, 2018, 06:24 PM | |
| JUNO | Juno Therapeutics, Inc. | NELSEN ROBERT | Director | Mar 05, 2018 | Option Exercise | $87.00 | 10,552,390 | 918,057,930 | 0 | Mar 07, 2018, 06:23 PM | |
| JUNO | Juno Therapeutics, Inc. | NELSEN ROBERT | Director | Mar 05, 2018 | Option Exercise | $87.00 | 54,058 | 4,703,046 | 3,234 | Mar 07, 2018, 06:23 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Mar 05, 2018 | Option Exercise | $87.00 | 705,525 | 61,380,675 | 0 | Mar 07, 2018, 06:21 PM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | CFO & Head, Corp. Development | Mar 05, 2018 | Option Exercise | $87.00 | 542,365 | 47,185,755 | 147,162 | Mar 07, 2018, 06:20 PM | |
| JUNO | Juno Therapeutics, Inc. | FLATLEY JAY T | Director | Mar 05, 2018 | Option Exercise | $87.00 | 31,500 | 2,740,500 | 0 | Mar 07, 2018, 06:19 PM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel & Secretary | Mar 05, 2018 | Option Exercise | $87.00 | 5,558 | 483,546 | 79,825 | Mar 07, 2018, 06:16 PM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel & Secretary | Mar 05, 2018 | Option Exercise | $87.00 | 26,869 | 2,337,603 | 0 | Mar 07, 2018, 06:16 PM | |
| JUNO | Juno Therapeutics, Inc. | Bishop Hans Edgar | CEO & President | Mar 05, 2018 | Option Exercise | $87.00 | 2,312,777 | 201,211,599 | 184,281 | Mar 07, 2018, 06:15 PM | |
| JUNO | Juno Therapeutics, Inc. | Barron Hal | Director | Mar 05, 2018 | Option Exercise | $87.00 | 103,780 | 9,028,860 | 3,780 | Mar 07, 2018, 06:14 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 12, 2018 | Sale | $85.55 | 4,159 | 355,802 | 89,612 | Feb 15, 2018, 07:31 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 12, 2018 | Sale | $85.55 | 4,157 | 355,631 | 89,614 | Feb 14, 2018, 07:24 PM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | CFO & Head, Corp. Development | Feb 07, 2018 | Option Exercise | $85.49 | 1,704 | 145,675 | 790,763 | Feb 09, 2018, 07:32 PM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel & Secretary | Feb 07, 2018 | Option Exercise | $85.49 | 1,528 | 130,629 | 111,896 | Feb 09, 2018, 07:31 PM | |
| JUNO | Juno Therapeutics, Inc. | Bishop Hans Edgar | CEO & President | Feb 07, 2018 | Option Exercise | $85.49 | 4,346 | 371,540 | 2,564,509 | Feb 09, 2018, 07:29 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 07, 2018 | Option Exercise | $85.49 | 2,700 | 230,823 | 93,771 | Feb 09, 2018, 07:27 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 08, 2018 | Sale | $53.81 | 6,994 | 376,313 | 97,268 | Feb 09, 2018, 07:27 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Feb 01, 2018 | Sale | $68.77 | 8,334 | 573,129 | 100,638 | Feb 02, 2018, 07:26 PM | |
| JUNO | Juno Therapeutics, Inc. | FLATLEY JAY T | Director | May 30, 2017 | Buy | $22.92 | 10,000 | 229,200 | 31,500 | Jan 30, 2018, 04:29 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Jan 22, 2018 | Option Exercise | $69.00 | 205,078 | 14,151,407 | 173,371 | Jan 24, 2018, 06:46 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Jan 17, 2018 | Sale | $44.88 | 58,262 | 2,614,678 | 99,963 | Jan 19, 2018, 09:00 PM | |
| JUNO | Juno Therapeutics, Inc. | Bishop Hans Edgar | CEO & President | Jan 16, 2018 | Sale | $27.21 | 516,000 | 14,041,498 | 2,772,679 | Jan 18, 2018, 09:30 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Jan 08, 2018 | Sale | $48.21 | 12,724 | 613,392 | 739,550 | Jan 09, 2018, 09:05 PM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | CFO & Head, Corp. Development | Dec 21, 2017 | Sale | $26.74 | 17,500 | 467,974 | 772,082 | Dec 22, 2017, 04:59 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Dec 21, 2017 | Sale | $44.76 | 36,000 | 1,611,356 | 744,392 | Dec 22, 2017, 04:58 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Dec 18, 2017 | Sale | $44.96 | 1,816 | 81,647 | 70,832 | Dec 20, 2017, 04:37 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Nov 08, 2017 | Option Exercise | $55.98 | 684 | 38,290 | 72,648 | Nov 09, 2017, 07:32 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Nov 02, 2017 | Sale | $40.12 | 13,332 | 534,880 | 79,998 | Nov 03, 2017, 07:30 PM | |
| JUNO | Juno Therapeutics, Inc. | AGARWAL SUNIL | President of R & D | Oct 02, 2017 | Sale | $44.76 | 7,285 | 326,088 | 84,549 | Oct 04, 2017, 07:31 PM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel & Secretary | Sep 14, 2017 | Sale | $44.92 | 28,000 | 1,257,766 | 55,970 | Sep 14, 2017, 07:33 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Sep 13, 2017 | Sale | $44.95 | 12,850 | 577,608 | 37,439 | Sep 14, 2017, 07:31 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Sep 07, 2017 | Sale | $42.66 | 12,000 | 511,865 | 783,536 | Sep 08, 2017, 07:29 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Aug 29, 2017 | Sale | $39.95 | 12,869 | 514,117 | 50,289 | Aug 31, 2017, 07:44 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Aug 07, 2017 | Sale | $30.34 | 12,000 | 364,091 | 788,985 | Aug 09, 2017, 07:43 PM | |
| JUNO | Juno Therapeutics, Inc. | Crestline SI (GP), L.P. | 10% Owner | Jul 13, 2017 | Sale | $27.00 | 8,000,000 | 216,000,000 | 9,166,130 | Jul 17, 2017, 05:48 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Jul 07, 2017 | Sale | $29.39 | 24,000 | 705,320 | 801,385 | Jul 07, 2017, 07:49 PM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | CFO & Head, Corp. Development | Jul 03, 2017 | Sale | $19.36 | 17,500 | 338,800 | 736,189 | Jul 05, 2017, 06:41 PM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | CFO & Head, Corp. Development | Jun 27, 2017 | Sale | $19.36 | 17,500 | 338,801 | 736,189 | Jun 29, 2017, 07:43 PM | |
| JUNO | Juno Therapeutics, Inc. | EVNIN ANTHONY B | Director | Jun 20, 2017 | Buy | $24.40 | 9,000 | 219,600 | 66,301 | Jun 21, 2017, 05:01 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Jun 07, 2017 | Sale | $23.60 | 24,000 | 566,362 | 833,373 | Jun 09, 2017, 07:37 PM | |
| JUNO | Juno Therapeutics, Inc. | FLATLEY JAY T | Director | May 24, 2017 | Buy | $25.15 | 10,000 | 251,517 | 11,500 | May 26, 2017, 06:04 PM | |
| JUNO | Juno Therapeutics, Inc. | FLATLEY JAY T | Director | May 26, 2017 | Buy | $24.37 | 10,000 | 243,700 | 21,500 | May 26, 2017, 06:04 PM | |
| JUNO | Juno Therapeutics, Inc. | AGARWAL SUNIL | President of R & D | Apr 13, 2017 | Option Exercise | $24.01 | 4,793 | 115,080 | 91,834 | Apr 17, 2017, 07:58 PM | |
| JUNO | Juno Therapeutics, Inc. | EVNIN ANTHONY B | Director | Mar 10, 2017 | Buy | $22.11 | 8,000 | 176,885 | 56,990 | Mar 13, 2017, 06:57 PM | |
| JUNO | Juno Therapeutics, Inc. | Azelby Robert | EVP & Chief Commercial Officer | Nov 10, 2016 | Sale | $24.14 | 12,921 | 311,848 | 35,719 | Nov 10, 2016, 08:56 PM | |
| JUNO | Juno Therapeutics, Inc. | Bishop Hans Edgar | CEO & President | Sep 27, 2016 | Sale | $19.68 | 88,000 | 1,731,840 | 2,490,859 | Sep 29, 2016, 06:02 PM | |
| JUNO | Juno Therapeutics, Inc. | Bishop Hans Edgar | CEO & President | Sep 19, 2016 | Option Exercise | $18.18 | 856 | 15,562 | 2,518,537 | Sep 21, 2016, 07:34 PM | |
| JUNO | Juno Therapeutics, Inc. | Bishop Hans Edgar | CEO & President | Sep 20, 2016 | Option Exercise | $18.18 | 12,600 | 229,071 | 2,524,409 | Sep 21, 2016, 07:34 PM | |
| JUNO | Juno Therapeutics, Inc. | Bishop Hans Edgar | CEO & President | Sep 21, 2016 | Option Exercise | $28.56 | 83,364 | 2,381,110 | 2,524,166 | Sep 21, 2016, 07:34 PM | |
| JUNO | Juno Therapeutics, Inc. | Bishop Hans Edgar | CEO & President | Sep 08, 2016 | Option Exercise | $18.21 | 46,084 | 839,125 | 2,541,151 | Sep 09, 2016, 08:07 PM | |
| JUNO | Juno Therapeutics, Inc. | Bishop Hans Edgar | CEO & President | Aug 31, 2016 | Option Exercise | $22.98 | 60,846 | 1,398,134 | 2,560,782 | Sep 02, 2016, 08:37 PM | |
| JUNO | Juno Therapeutics, Inc. | Bishop Hans Edgar | CEO & President | Jun 30, 2016 | Sale | $29.58 | 159,250 | 4,710,956 | 2,657,859 | Sep 02, 2016, 08:36 PM | |
| JUNO | Juno Therapeutics, Inc. | Bishop Hans Edgar | CEO & President | Jun 30, 2016 | Option Exercise | $29.58 | 159,250 | 4,710,956 | 2,657,859 | Jul 01, 2016, 08:36 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Jun 24, 2016 | Sale | $40.71 | 12,000 | 488,496 | 846,799 | Jun 24, 2016, 05:56 PM | |
| JUNO | Juno Therapeutics, Inc. | Levitsky Hyam | EVP, Research & CSO | Jun 17, 2016 | Sale | $42.77 | 12,418 | 531,081 | 117,000 | Jun 21, 2016, 04:36 PM | |
| JUNO | Juno Therapeutics, Inc. | Bishop Hans Edgar | CEO & President | Jun 09, 2016 | Sale | $31.47 | 144,750 | 4,555,784 | 2,704,609 | Jun 13, 2016, 07:21 AM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | CFO & Head, Corp. Development | Jun 10, 2016 | Sale | $43.32 | 30,000 | 1,299,530 | 716,052 | Jun 13, 2016, 07:20 AM | |
| JUNO | Juno Therapeutics, Inc. | Levitsky Hyam | EVP, Research & CSO | May 27, 2016 | Option Exercise | $42.04 | 16,454 | 691,726 | 129,118 | May 27, 2016, 08:02 PM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel & Secretary | May 19, 2016 | Sale | $39.03 | 3,116 | 121,603 | 55,511 | May 20, 2016, 05:37 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | May 18, 2016 | Sale | $40.00 | 12,000 | 480,000 | 858,799 | May 20, 2016, 05:35 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Apr 15, 2016 | Sale | $42.90 | 12,000 | 514,857 | 872,792 | Apr 19, 2016, 07:17 PM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel & Secretary | Apr 19, 2016 | Sale | $43.12 | 3,200 | 137,999 | 57,933 | Apr 19, 2016, 07:15 PM | |
| JUNO | Juno Therapeutics, Inc. | EVNIN ANTHONY B | Director | Mar 28, 2016 | Buy | $36.58 | 8,000 | 292,662 | 58,000 | Mar 30, 2016, 04:54 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Mar 22, 2016 | Sale | $40.00 | 12,000 | 480,000 | 882,499 | Mar 22, 2016, 06:42 PM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel & Secretary | Mar 18, 2016 | Sale | $38.18 | 3,200 | 122,171 | 61,865 | Mar 18, 2016, 05:28 PM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | See Remarks | Mar 04, 2016 | Sale | $45.00 | 5,000 | 225,000 | 730,000 | Mar 04, 2016, 09:00 PM | |
| JUNO | Juno Therapeutics, Inc. | Crestline Management, LP | 10% Owner | Mar 01, 2016 | Sale | $39.00 | 8,600,000 | 335,400,000 | 17,166,130 | Mar 03, 2016, 05:10 PM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | See Remarks | Mar 01, 2016 | Sale | $37.58 | 30,000 | 1,127,342 | 762,987 | Mar 02, 2016, 09:03 PM | |
| JUNO | Juno Therapeutics, Inc. | Bishop Hans Edgar | See Remarks | Feb 29, 2016 | Sale | $24.51 | 144,750 | 3,548,445 | 2,741,359 | Mar 02, 2016, 09:02 PM | |
| JUNO | Juno Therapeutics, Inc. | Frohlich Mark W | See Remarks | Feb 29, 2016 | Sale | $35.27 | 20,000 | 705,341 | 919,883 | Mar 02, 2016, 09:01 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Mar 02, 2016 | Sale | $40.42 | 24,000 | 970,023 | 895,259 | Mar 02, 2016, 09:00 PM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel and Secretary | Feb 19, 2016 | Sale | $34.50 | 3,200 | 110,389 | 63,883 | Feb 19, 2016, 09:00 PM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel and Secretary | Jan 19, 2016 | Sale | $33.55 | 3,200 | 107,373 | 67,683 | Jan 20, 2016, 08:00 PM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel and Secretary | Dec 18, 2015 | Sale | $45.39 | 3,200 | 145,235 | 71,393 | Dec 21, 2015, 07:00 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Dec 15, 2015 | Sale | $45.71 | 12,000 | 548,562 | 926,284 | Dec 17, 2015, 07:01 PM | |
| JUNO | Juno Therapeutics, Inc. | Bishop Hans Edgar | CEO and President | Dec 15, 2015 | Sale | $31.11 | 145,500 | 4,526,851 | 2,778,859 | Dec 17, 2015, 07:00 PM | |
| JUNO | Juno Therapeutics, Inc. | Harr Steve | See Remarks | Dec 10, 2015 | Sale | $46.43 | 35,000 | 1,625,074 | 768,600 | Dec 11, 2015, 09:00 PM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel and Secretary | Nov 19, 2015 | Sale | $52.97 | 3,200 | 169,500 | 71,505 | Nov 20, 2015, 08:00 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Nov 13, 2015 | Sale | $49.51 | 12,000 | 594,078 | 930,999 | Nov 13, 2015, 08:00 PM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel and Secretary | Oct 19, 2015 | Sale | $49.85 | 3,200 | 159,518 | 76,236 | Oct 19, 2015, 09:00 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Oct 15, 2015 | Sale | $50.00 | 8,000 | 400,000 | 942,499 | Oct 16, 2015, 07:00 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Oct 12, 2015 | Sale | $50.00 | 16,000 | 800,008 | 950,499 | Oct 13, 2015, 06:13 AM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel and Secretary | Sep 18, 2015 | Sale | $42.50 | 11,850 | 503,629 | 80,620 | Sep 18, 2015, 06:41 PM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel and Secretary | Aug 19, 2015 | Sale | $40.15 | 11,850 | 475,733 | 90,850 | Aug 20, 2015, 08:00 PM | |
| JUNO | Juno Therapeutics, Inc. | EVNIN ANTHONY B | Director | Jul 27, 2015 | Sale | $47.98 | 227,354 | 10,907,594 | 146,614 | Jul 29, 2015, 11:38 AM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel and Secretary | Jul 17, 2015 | Sale | $50.55 | 11,850 | 598,977 | 102,950 | Jul 17, 2015, 06:02 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Jul 15, 2015 | Sale | $53.34 | 8,000 | 426,727 | 966,616 | Jul 17, 2015, 06:00 PM | |
| JUNO | Juno Therapeutics, Inc. | BRATTON DOUGLAS K | 10% Owner | Jul 02, 2015 | Sale | $54.75 | 40,000 | 2,190,000 | 182,669 | Jul 02, 2015, 06:00 PM | |
| JUNO | Juno Therapeutics, Inc. | EVNIN ANTHONY B | Director | Jun 26, 2015 | Sale | $47.03 | 283,333 | 13,325,976 | 692,953 | Jun 29, 2015, 09:23 PM | |
| JUNO | Juno Therapeutics, Inc. | EVNIN ANTHONY B | Director | Jun 25, 2015 | Sale | $49.13 | 300,000 | 14,739,506 | 1,025,991 | Jun 29, 2015, 09:23 PM | |
| JUNO | Juno Therapeutics, Inc. | Cassidy Bernard J | General Counsel and Secretary | Jun 24, 2015 | Sale | $51.34 | 11,850 | 608,336 | 115,445 | Jun 25, 2015, 05:30 PM | |
| JUNO | Juno Therapeutics, Inc. | Klausner Richard | Director | Jun 23, 2015 | Sale | $52.29 | 8,000 | 418,302 | 977,600 | Jun 25, 2015, 05:30 PM | |
| JUNO | Juno Therapeutics, Inc. | BRATTON DOUGLAS K | 10% Owner | Jun 23, 2015 | Sale | $50.92 | 135,000 | 6,874,200 | 357,669 | Jun 25, 2015, 04:51 PM | |
| JUNO | Juno Therapeutics, Inc. | BRATTON DOUGLAS K | 10% Owner | Jun 24, 2015 | Sale | $51.33 | 135,000 | 6,929,550 | 222,669 | Jun 25, 2015, 04:51 PM | |
| JUNO | Juno Therapeutics, Inc. | EVNIN ANTHONY B | Director | Jun 17, 2015 | Sale | $53.05 | 300,000 | 15,914,906 | 1,659,858 | Jun 19, 2015, 08:58 PM | |
| JUNO | Juno Therapeutics, Inc. | EVNIN ANTHONY B | Director | Jun 18, 2015 | Sale | $52.70 | 283,333 | 14,932,567 | 1,371,430 | Jun 19, 2015, 08:58 PM | |
| JUNO | Juno Therapeutics, Inc. | Crestline Management, LP | 10% Owner | Dec 23, 2014 | Buy | $24.00 | 625,000 | 15,000,000 | 988,398 | Dec 24, 2014, 06:05 AM | |
| JUNO | Juno Therapeutics, Inc. | Crestline Investors, Inc. | 10% Owner | Dec 19, 2014 | Buy | $25.00 | 625,000 | 15,625,000 | 988,398 | Dec 23, 2014, 04:55 PM | |
| JUNO | Juno Therapeutics, Inc. | Barron Hal | Director | Dec 23, 2014 | Buy | $24.00 | 100,000 | 2,400,000 | 100,000 | Dec 23, 2014, 04:36 PM |
Menu